Parkinson's Disease Market Research Reports & Industry Analysis
As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately.
There is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, patients are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms.
Parkinson's Disease Industry Research & Market Reports
-
Parkinson's Disease Therapeutics Market by Type (Intestinal Infusion, Oral, Subcutaneous), Drug Class (Anticholinergic, Carbidopa/Levodopa, COMT Inhibitor), Distribution Channel, End Use - Global Forecast 2024-2030
... 3.15 billion in 2023 and expected to reach USD 3.49 billion in 2024, at a CAGR 10.88% to reach USD 6.51 billion by 2030. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market FPNV Positioning Matrix The FPNV ... Read More
-
Central Nervous System Biomarkers Market by Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease Indication (Alzheimer’s Disease, Multiple Sclerosis, Parkinson’s Disease), Application, End-User - Global Forecast 2024-2030
... estimated at USD 4.37 billion in 2023 and expected to reach USD 4.81 billion in 2024, at a CAGR 10.39% to reach USD 8.73 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Neurology Patient Monitoring Market by Device (Cerebral Oximeters, Electroencephalography Monitors, Intracranial Pressure Monitors), Disease Type (Epilepsy, Parkinson's Disease, Sleep Disorders), End-User - Global Forecast 2024-2030
... 5.18 billion in 2023 and expected to reach USD 5.55 billion in 2024, at a CAGR 7.90% to reach USD 8.84 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating ... Read More
-
Middle East & Africa Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The Middle East & Africa deep brain simulation market is expected to grow from US$ 25.64 million in ... Read More
-
South & Central America Deep Brain Simulation Market Forecast to 2030 - Regional Analysis - by Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator, and Software and Accessories), Application (Parkinson\'s Disease, Tremor, Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others)
... Dystonia, Epilepsy, Alzheimer\'s Disease, and Others), and End User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, and Others) The South & Central America deep brain simulation market is expected to grow from US$ 27.53 million in ... Read More
-
Global Parkinson's Disease (PD) Drugs Market Research Report 2024(Status and Outlook)
... turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The Global Parkinson's Disease (PD) Drugs Market Size was estimated at USD 5775.68 ... Read More
-
Treatment Syndromes Dementia Movement Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... and Africa) Leading Pharmaceutical Companies Aim to Address Rising Incidence of Cognitive Defects The global market for the treatment of syndromes related to dementia and movement disorders has witnessed remarkable growth in recent years, as ... Read More
-
Freeze of Gait Market Research Report Forecast till 2030
... is one of the critical driving components for market advancement. Parkinson's contamination is an issue of the central tactile framework that causes inadvertent or wild turns of events, like solidness, shaking, and issue with coordination ... Read More
-
Neurosurgery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 21.1 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028. Neurosurgery devices refer to various tools and instruments that are used for conducting surgeries and treating various pathologies in the ... Read More
-
Neurostimulation: Technologies and Global Markets
... devices (invasive and noninvasive) and their current and historical market revenues. Neurostimulation technologies and devices include spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, hypoglossal nerve stimulation, transcutaneous electrical nerve stimulation, ... Read More
-
Optogenetics Actuators and Sensors Market Report: Trends, Forecast and Competitive Analysis to 2030
... the retinal disorder, parkinson’s disease, anxiety & depression, autism, and schizophrenia markets. The global optogenetics actuators and sensors market is expected to reach an estimated $0.8 billion by 2030 with a CAGR of 2.1% from ... Read More
-
DNA Synthesis Technologies and Services Market, 2022-2035
... worth highlighting that several research studies are being conducted to evaluate the use of oligonucleotides, especially DNA, as a therapeutic intervention for treatment of various medical conditions. The approval of the first antisense oligonucleotide drug, ... Read More
-
Parkinson's Disease by Major Markets - Size, Trends and Drug Forecast including Epidemiology, Disease Management, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Pipeline Analysis to 2029
... Germany, Italy, Spain, UK, Japan) and provides an Excel-based forecast model for the Parkinson's Disease market through 2029. Parkinson’s disease (PD) is a chronic and progressive disease. The primary pathological features of PD are loss ... Read More
-
2023 Global Forecast for Parkinson'S Disease Treatment Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2023 Global Forecast for Parkinson'S Disease (Pd) Drugs Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
Dementia Drugs Market by Indication (Lewy Body Dementia, Parkinson’s Disease Dementia, Alzheimer’s Disease, Vascular Dementia, and Others), Drug Class (Cholinesterase Inhibitors, NMDA Antagonists and its Combination Drugs), Distribution Channel (Retail Ph
... and Region 2023-2028 Market Overview: The global dementia drugs market reached US$ 16.95 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.7 Billion by 2028, exhibiting a growth rate (CAGR) ... Read More
-
Global Neurology Clinical Trials Market Size study & Forecast, by Phase (Phase I, Phase II, Phase III, Phase IV) by Study Design (Interventional, Observational, Expanded Access), by Indication (Epilepsy, Parkinson's Disease (PD), Huntington's Disease, Stroke, Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030
... Traumatic Brain Injury (TBI), Others) and Regional Analysis, 2023-2030 Global Neurology Clinical Trials Market is valued at approximately USD 5.24 billion in 2022 and is anticipated to grow with a healthy growth rate of more ... Read More
-
Global Neurotech Devices Market Size study & Forecast, by Product (Neurostimulation, Neuroprostheses, Neurosensing, Neurorehabilitation Devices), by Conditions (Pain Management, Cognitive Disorders, Epilepsy, Urinary and Fecal Incontinence, Hearing Conditions, Parkinson’s Disease, Depression, Sleep Disorders, Essential Tremor), by End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities) and Regional Analysis, 2022-2029
... by End-use (Hospitals, Ambulatory Surgical Centers, Homecare Facilities) and Regional Analysis, 2022-2029 Global Neurotech Devices Market is valued approximately USD 10.90 billion in 2021 and is anticipated to grow with a healthy growth rate of ... Read More
-
Brain Implant Market By Type (Deep brain stimulation, Vagus nerve stimulation), By Application (Parkinson's disease, Epilepsy, Others), By End User (Hospitals, Neurology clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
... valued for $1.4 billion in 2022 and is estimated to reach $4.5 billion by 2032, exhibiting a CAGR of 12.2% from 2023 to 2032. A brain implant is a medical device that is surgically implanted ... Read More
-
Global Transcranial Magnetic Stimulator Market - 2023-2030
... at a CAGR of 9.2% during the forecast period (2023-2030). Transcranial Magnetic Stimulation is a noninvasive technological breakthrough involving applying short magnetic pulses to elicit nerve cells in brain regions associated with major depression, Alzheimer's, ... Read More
-
Neurodegenerative Disease Market, By Indication Type (Parkinson's Disease, Alzheimer's Disease, Multiple Sclerosis, Huntington Disease, and Other Indication Types), By Drug Type (N-methyl-D-aspartate Receptor antagonists, Cholinesterase Inhibitors, Dopamine Agonists, Immunomodulatory Drugs, and Other Drug Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030 Neurodegenerative disease is a type of disease in which cells of the central ... Read More
-
Global Parkinson's Disease Market Growth (Status and Outlook) 2023-2029
... comprehensive analysis by region and market sector of projected Parkinson's Disease sales for 2023 through 2029. With Parkinson's Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in ... Read More
-
Global Parkinson's Disease Therapeutics Market Growth (Status and Outlook) 2023-2029
... 2022, providing a comprehensive analysis by region and market sector of projected Parkinson's Disease Therapeutics sales for 2023 through 2029. With Parkinson's Disease Therapeutics sales broken down by region, market sector and sub-sector, this report ... Read More
-
Immunoassay for Neurological Biomarkers Market Size, Share & Trends Analysis Report By Product, By Disease (Alzheimer's Disease, Parkinson's Disease, Multiple Sclerosis), By Application, By Region, And Segment Forecasts, 2023 - 2030
... Market Growth & Trends The global immunoassay for neurological biomarkers market size is expected to reach USD 2.24 billion by 2030, registering a CAGR of 17.8% from 2023 to 2030, according to a new report ... Read More
-
Neurodegenerative Drugs Market By Drug Class (Dopamine agonist , Decarboxylase inhibitors , Cholinesterase Inhibitors , Immunomodulators, Others ), By Indication (Parkinson’s Disease, Alzheimer’s Disease, Multiple Sclerosis , Others), By Distribution Channel (Hospital Pharmacies, Online Providers, Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Drug Stores and Retail Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031 The neurodegenerative drugs market valued for $36,277.20 million in 2021 and is estimated to reach $74,809.38 million by 2031, exhibiting a CAGR of ... Read More
Research Assistance
